Belluscura PLC (GB:BELL) has released an update.
Belluscura PLC reports a significant revenue growth in 2024, driven by the launch of its new DISCOV-R device, which has just received crucial Medicare reimbursement codes. Despite funding delays impacting Q4 revenue projections, the company remains optimistic about future growth, supported by strong interest from major distributors.
For further insights into GB:BELL stock, check out TipRanks’ Stock Analysis page.
